India’s Authorities Approve Start of WHO Solidarity Trial in Gujarat India & Challenges at GMERs

India’s Authorities Approve Start of WHO Solidarity Trial in Gujarat India & Challenges at GMERs

The World Health Organization’s Solidarity Trial covering COVID-19 launches in Gujarat India at sites including SVP College in Ahmedabad, GMERs, Vadodara; New Civil Hospital, Surat and PDU Medical College, Rajkot. The study will also be conducted at B.J. Medical College in Ahmedabad. The trial is being conducted in association with the Indian Council of Medical Research as recently announced by Principal Secretary of Health Jayanti Ravi. 

COVID-19 Pandemic in Gujarat

The virus’ growth has accelerated in the state of Gujarat as the COVID-19 death toll has crossed the 300-figure mark now at 319, according to The Week. On the western coast of India, Gujarat primarily lies on the Kathiawar peninsula and is home to about 60.4 million people making it the ninth largest state by population.

The Study

WHO’s Solidarity Trial received a lot of interest within the TrialSite News viewer base. As reported, the trial covers the following therapies:

Remdesivir: The new coronavirus is giving this compound a second chance to shine. Originally developed by Gilead to combat Ebola and related viruses, remdesivir shuts down viral replication by inhibiting a key viral enzyme, the RNA-dep...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee